Doo Yeon Kim - Publications

Affiliations: 
Neurology Harvard Medical School - Massachusetts General Hospital 

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Kim E, Kim H, Jedrychowski MP, Bakiasi G, Park J, Kruskop J, Choi Y, Kwak SS, Quinti L, Kim DY, Wrann CD, Spiegelman BM, Tanzi RE, Choi SH. Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron. PMID 37689059 DOI: 10.1016/j.neuron.2023.08.012  0.788
2023 Jorfi M, Park J, Hall CK, Lin CJ, Chen M, von Maydell D, Kruskop JM, Kang B, Choi Y, Prokopenko D, Irimia D, Kim DY, Tanzi RE. Infiltrating CD8 T cells exacerbate Alzheimer's disease pathology in a 3D human neuroimmune axis model. Nature Neuroscience. PMID 37620442 DOI: 10.1038/s41593-023-01415-3  0.782
2023 Boyarko B, Podvin S, Greenberg B, Momper JD, Huang Y, Gerwick WH, Bang AG, Quinti L, Griciuc A, Kim DY, Tanzi RE, Feldman HH, Hook V. Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease. Frontiers in Pharmacology. 14: 1190402. PMID 37601062 DOI: 10.3389/fphar.2023.1190402  0.664
2023 Wittrahm R, Takalo M, Kuulasmaa T, Mäkinen PM, Mäkinen P, Končarević S, Fartzdinov V, Selzer S, Kokkola T, Antikainen L, Martiskainen H, Kemppainen S, Marttinen M, Jeskanen H, Rostalski H, ... ... Kim DY, et al. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models. Neurobiology of Disease. 106140. PMID 37120095 DOI: 10.1016/j.nbd.2023.106140  0.689
2023 Hebisch M, Klostermeier S, Wolf K, Boccaccini AR, Wolf SE, Tanzi RE, Kim DY. The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2205037. PMID 36642841 DOI: 10.1002/advs.202205037  0.681
2022 Ning S, Jorfi M, Patel SR, Kim DY, Tanzi RE. Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease. Frontiers in Neuroscience. 16: 854992. PMID 35401082 DOI: 10.3389/fnins.2022.854992  0.795
2021 Kim JJ, Jorfi M, Tanzi RE, Kim DY, Doyle PS, Irimia D. Patterning of interconnected human brain spheroids. Lab On a Chip. PMID 34286713 DOI: 10.1039/d0lc01112f  0.814
2020 Chun H, Im H, Kang YJ, Kim Y, Shin JH, Won W, Lim J, Ju Y, Park YM, Kim S, Lee SE, Lee J, Woo J, Hwang Y, Cho H, ... ... Kim D, ... ... Kim DY, et al. Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via HO production. Nature Neuroscience. PMID 33199896 DOI: 10.1038/s41593-020-00735-y  0.436
2020 Cenini G, Hebisch M, Iefremova V, Flitsch LJ, Breitkreuz Y, Tanzi RE, Kim DY, Peitz M, Brüstle O. Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models. Molecular and Cellular Neurosciences. 103568. PMID 33068718 DOI: 10.1016/j.mcn.2020.103568  0.681
2020 Kwak SS, Washicosky KJ, Brand E, von Maydell D, Aronson J, Kim S, Capen DE, Cetinbas M, Sadreyev R, Ning S, Bylykbashi E, Xia W, Wagner SL, Choi SH, Tanzi RE, ... Kim DY, et al. Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease. Nature Communications. 11: 1377. PMID 32170138 DOI: 10.1038/S41467-020-15120-3  0.742
2019 Shin Y, Choi SH, Kim E, Bylykbashi E, Kim JA, Chung S, Kim DY, Kamm RD, Tanzi RE. Blood-Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 6: 1900962. PMID 31637161 DOI: 10.1002/Advs.201900962  0.712
2019 Chun H, Kim Y, Kang YJ, Im H, Shin JH, Ju Y, Won W, Park YM, Lim J, Lee J, Woo J, Hwang Y, Jo S, Wetzel I, Park J, ... Kim D, ... ... Kim DY, et al. Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via excessive H2O2-production Ibro Reports. 6: S118. DOI: 10.1016/J.Ibror.2019.07.377  0.436
2019 Ning S, Rompala A, Shanmugam NK, Kim I, Rodriguez AS, Hartmann S, Patel SR, Choi SH, Tanzi RE, Kim DY. Rapid removal of amyloid-β aggregates using superparamagnetic nanoparticles Ibro Reports. 6: S378. DOI: 10.1016/J.Ibror.2019.07.1202  0.587
2018 Norambuena A, Wallrabe H, Cao R, Wang DB, Silva A, Svindrych Z, Periasamy A, Hu S, Tanzi RE, Kim DY, Bloom GS. A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers. The Embo Journal. PMID 30348864 DOI: 10.15252/Embj.2018100241  0.669
2018 Choi SH, Bylykbashi E, Chatila ZK, Lee SW, Pulli B, Clemenson GD, Kim E, Rompala A, Oram MK, Asselin C, Aronson J, Zhang C, Miller SJ, Lesinski A, Chen JW, ... Kim DY, et al. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model. Science (New York, N.Y.). 361. PMID 30190379 DOI: 10.1126/Science.Aan8821  0.631
2018 Chatila ZK, Kim E, Berlé C, Bylykbashi E, Rompala A, Oram MK, Gupta D, Kwak SS, Kim YH, Kim DY, Choi SH, Tanzi RE. BACE1 Regulates Proliferation and Neuronal Differentiation of Newborn Cells in the Adult Hippocampus in Mice. Eneuro. 5. PMID 30079376 DOI: 10.1523/ENEURO.0067-18.2018  0.626
2018 Yu YJ, Kim YH, Na K, Min SY, Hwang OK, Park DK, Kim DY, Choi SH, Kamm RD, Chung S, Kim JA. Hydrogel-incorporating unit in a well: 3D cell culture for high-throughput analysis. Lab On a Chip. PMID 30043033 DOI: 10.1039/C8Lc00525G  0.448
2018 Park J, Wetzel I, Marriott I, Dréau D, D'Avanzo C, Kim DY, Tanzi RE, Cho H. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease. Nature Neuroscience. PMID 29950669 DOI: 10.1038/S41593-018-0175-4  0.818
2018 Jorfi M, D'Avanzo C, Tanzi RE, Kim DY, Irimia D. Human Neurospheroid Arrays for In Vitro Studies of Alzheimer's Disease. Scientific Reports. 8: 2450. PMID 29402979 DOI: 10.1038/S41598-018-20436-8  0.787
2017 Gong Y, Sasidharan N, Laheji F, Frosch M, Musolino P, Tanzi R, Kim DY, Biffi A, El Khoury J, Eichler F. Microglial dysfunction as a key pathologic change in adrenomyeloneuropathy. Annals of Neurology. PMID 29059709 DOI: 10.1002/Ana.25085  0.306
2017 Jorfi M, D'Avanzo C, Kim DY, Irimia D. Three-Dimensional Models of the Human Brain Development and Diseases. Advanced Healthcare Materials. PMID 28845922 DOI: 10.1002/Adhm.201700723  0.791
2017 Wagner SL, Rynearson KD, Duddy SK, Zhang C, Nguyen PD, Becker A, Vo U, Masliah D, Monte L, Klee JB, Echmalian CM, Xia W, Quinti L, Johnson G, Lin JH, ... Kim DY, et al. Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606. The Journal of Pharmacology and Experimental Therapeutics. PMID 28416568 DOI: 10.1124/Jpet.117.240861  0.656
2017 Quinti L, Forte AM, Kim DY, Griciuc A, Tanzi RE. A NOVEL DRUG-SCREENING PLATFORM IN MICROGLIAL CELLS IDENTIFIES POTENTIAL AD DRUGS Alzheimer's & Dementia. 13: P1485. DOI: 10.1016/J.Jalz.2017.07.564  0.599
2016 Choi SH, Kim YH, Quinti L, Tanzi RE, Kim DY. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish". Molecular Neurodegeneration. 11: 75. PMID 27938410 DOI: 10.1186/S13024-016-0139-7  0.733
2016 Tanzi R, Kim DY. EC-03-01: Reconstructing Alzheimer Amyloid and Tau Pathology in 3D Cell Cultures from Stem Cells Alzheimer's & Dementia. 12: P268-P269. DOI: 10.1016/J.Jalz.2016.06.485  0.688
2015 Choi SH, Kim YH, D'Avanzo C, Aronson J, Tanzi RE, Kim DY. Recapitulating amyloid β and tau pathology in human neural cell culture models: clinical implications. Us Neurology. 11: 102-105. PMID 27019672 DOI: 10.17925/Usn.2015.11.02.102  0.739
2015 Agsten M, Hessler S, Lehnert S, Volk T, Rittger A, Hartmann S, Raab C, Kim DY, Groemer TW, Schwake M, Alzheimer C, Huth T. BACE1 modulates gating of KCNQ1 (Kv7.1) and cardiac delayed rectifier KCNQ1/KCNE1 (IKs). Journal of Molecular and Cellular Cardiology. PMID 26454161 DOI: 10.1016/J.Yjmcc.2015.10.006  0.364
2015 Hyman BT, Growdon JH, Albers MW, Buckner RL, Chhatwal J, Gomez-Isla MT, Haass C, Hudry E, Jack CR, Johnson KA, Khachaturian ZS, Kim DY, Martin JB, Nitsch RM, Rosen BR, et al. Massachusetts Alzheimer's Disease Research Center: Progress and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26297855 DOI: 10.1016/J.Jalz.2015.06.1887  0.639
2015 D'Avanzo C, Aronson J, Kim YH, Choi SH, Tanzi RE, Kim DY. Alzheimer's in 3D culture: Challenges and perspectives. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 37: 1139-48. PMID 26252541 DOI: 10.1002/Bies.201500063  0.739
2015 Kim YH, Choi SH, D'Avanzo C, Hebisch M, Sliwinski C, Bylykbashi E, Washicosky KJ, Klee JB, Brüstle O, Tanzi RE, Kim DY. A 3D human neural cell culture system for modeling Alzheimer's disease. Nature Protocols. 10: 985-1006. PMID 26068894 DOI: 10.1038/Nprot.2015.065  0.738
2015 D'Avanzo C, Sliwinski C, Wagner SL, Tanzi RE, Kim DY, Kovacs DM. γ-Secretase modulators reduce endogenous amyloid β42 levels in human neural progenitor cells without altering neuronal differentiation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 25903103 DOI: 10.1096/fj.15-271015  0.715
2014 Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D'Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, ... ... Kim DY, et al. A three-dimensional human neural cell culture model of Alzheimer's disease. Nature. 515: 274-8. PMID 25307057 DOI: 10.1038/Nature13800  0.822
2014 Gautam V, D'Avanzo C, Hebisch M, Kovacs DM, Kim DY. BACE1 activity regulates cell surface contactin-2 levels. Molecular Neurodegeneration. 9: 4. PMID 24405708 DOI: 10.1186/1750-1326-9-4  0.642
2014 Kim DY, Wertz MH, Gautam V, D'Avanzo C, Bhattacharyya R, Kovacs DM. The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells. Neuro-Degenerative Diseases. 13: 64-8. PMID 24217025 DOI: 10.1159/000354669  0.574
2013 Suh J, Choi SH, Romano DM, Gannon MA, Lesinski AN, Kim DY, Tanzi RE. ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function. Neuron. 80: 385-401. PMID 24055016 DOI: 10.1016/J.Neuron.2013.08.035  0.661
2013 Sachse CC, Kim YH, Agsten M, Huth T, Alzheimer C, Kovacs DM, Kim DY. BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2458-67. PMID 23504710 DOI: 10.1096/Fj.12-214056  0.58
2013 Kim YH, Choi SH, Wagner S, Tanzi R, Kim DY. P4-015: A novel Alzheimer's disease model based on 3D-cultured human neural progenitor cells Alzheimer's & Dementia. 9: P710-P710. DOI: 10.1016/J.Jalz.2013.05.1403  0.677
2011 Kim DY, Kovacs DM. Surface trafficking of sodium channels in cells and in hippocampal slices. Methods in Molecular Biology (Clifton, N.J.). 793: 351-61. PMID 21913112 DOI: 10.1007/978-1-61779-328-8_23  0.567
2011 Kim DY, Gersbacher MT, Inquimbert P, Kovacs DM. Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. The Journal of Biological Chemistry. 286: 8106-16. PMID 21190943 DOI: 10.1074/Jbc.M110.134692  0.55
2010 Gersbacher MT, Kim DY, Bhattacharyya R, Kovacs DM. Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit. Molecular Neurodegeneration. 5: 61. PMID 21182789 DOI: 10.1186/1750-1326-5-61  0.578
2010 Kovacs DM, Gersbacher MT, Kim DY. Alzheimer's secretases regulate voltage-gated sodium channels. Neuroscience Letters. 486: 68-72. PMID 20817076 DOI: 10.1016/J.Neulet.2010.08.048  0.577
2010 Zhang C, Browne A, Kim DY, Tanzi RE. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage. Current Alzheimer Research. 7: 21-6. PMID 20205669 DOI: 10.2174/156720510790274428  0.657
2010 Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A, Moir RD, Domnitz SB, Frosch MP, Windisch M, Kovacs DM. The ACAT Inhibitor CP-113,818 Markedly Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease Neuron. 68: 1014. DOI: 10.1016/j.neuron.2010.11.028  0.426
2007 Huttunen HJ, Guénette SY, Peach C, Greco C, Xia W, Kim DY, Barren C, Tanzi RE, Kovacs DM. HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. The Journal of Biological Chemistry. 282: 28285-95. PMID 17684015 DOI: 10.1074/Jbc.M702951200  0.712
2007 Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, Pettingell WH, He P, Lee VM, Woolf CJ, Kovacs DM. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nature Cell Biology. 9: 755-64. PMID 17576410 DOI: 10.1038/Ncb1602  0.598
2007 Haapasalo A, Kim DY, Carey BW, Turunen MK, Pettingell WH, Kovacs DM. Presenilin/gamma-secretase-mediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with beta-catenin. The Journal of Biological Chemistry. 282: 9063-72. PMID 17259169 DOI: 10.1074/Jbc.M611324200  0.584
2007 Carey BW, Kim DY, Kovacs DM. Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins. The Biochemical Journal. 401: 121-7. PMID 17150042 DOI: 10.1042/Bj20060847  0.538
2006 Zhang M, Haapasalo A, Kim DY, Ingano LA, Pettingell WH, Kovacs DM. Presenilin/gamma-secretase activity regulates protein clearance from the endocytic recycling compartment. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1176-8. PMID 16645046 DOI: 10.1096/Fj.05-5531Fje  0.592
2006 Norambuena A, Wallrabe H, Cao R, Wang DB, Silva A, Svindrych Z, Periasamy A, Hu S, Tanzi RE, Kim DY, Bloom GS. O2-12-02: A NOVEL LYSOSOME TO MITOCHONDRIA SIGNALING PATHWAY REGULATES MITOCHONDRIAL ACTIVITY AND IS DISRUPTED BY AMYLOID-β OLIGOMERS Alzheimer's & Dementia. 14: P650-P651. DOI: 10.1016/J.Jalz.2018.06.2707  0.577
2005 Kim DY, Ingano LA, Carey BW, Pettingell WH, Kovacs DM. Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration. The Journal of Biological Chemistry. 280: 23251-61. PMID 15833746 DOI: 10.1074/Jbc.M412938200  0.547
2005 Kang HJ, Yoon WJ, Moon GJ, Kim DY, Sohn S, Kwon HJ, Gwag BJ. Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: An implication to Alzheimer's disease Neurobiology of Disease. 18: 450-458. PMID 15755671 DOI: 10.1016/J.Nbd.2004.12.004  0.434
2004 Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A, Moir RD, Domnitz SB, Frosch MP, Windisch M, Kovacs DM. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron. 44: 227-38. PMID 15473963 DOI: 10.1016/J.Neuron.2004.08.043  0.679
2004 Kim DY, MacKenzie Ingano LA, Carey BW, Pettingell W, Kovacs DM. P4-290 Voltage-gated sodium channel beta2 subunit is processed by alpha-, beta- and gamma-secretases, generating fragments elevated in AD brains Neurobiology of Aging. 25: S557-S558. DOI: 10.1016/S0197-4580(04)81848-7  0.353
2002 Kim DY, Ingano LA, Kovacs DM. Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. The Journal of Biological Chemistry. 277: 49976-81. PMID 12376527 DOI: 10.1074/Jbc.M210179200  0.561
Show low-probability matches.